×é°±ËáÊÇÉúÎïÖƼÁ£¨¿¹Ìå¡¢´¡¶Ù°ä¡¢ÒßÃçµÈ£©Öг£¼ûµÄ°±»ùËḨÁÏ£¬¾ßÓТٱè±á»º³åÌåϵ£»¢Ú¿¹Ñõ»¯£»¢Û¶³¸É±£»¤µÈ¶àÖÖ×÷Óá£
×é°±ËáÒѱ»¹ã·ºÓÃ×÷¿¹ÌåÒ©ÎïµÈµ°°×ÖƼÁµÄ±è±á»º³å¼Á£¬×é°±Ëỹ¿Éͨ¹ý·Ç¹²¼ÛÏ໥×÷ÓÃÎȶ¨¹Ì̬״̬ϵĵ°°×£¬×é°±ËáÑÎËáÑÎÔò¿É·ÀÖ¹µ°°×ÔÚ¶³¸É¹ý³ÌÖÐʧ»î¡£´ËÍ⣬×é°±ËỹÊÇÒ»ÖÖ¿¹Ñõ»¯¼Á£¬ÄÜÇå³ýÈÜÒºÖеÄôÇ»ù×ÔÓÉ»ù¡£Ä¿Ç°ÒÑ»ñÅúÉÏÊеĿ¹ÌåÒ©ÎïÖУ¬Óг¬¹ý40%µÄÖƼÁ´¦·½ÖÐÌí¼Ó×é°±Ëá¼°ÑÎËá×é°±Ëá¡£
×é°±ËáµÄÓ¦Óãº
·¡±·±á·¡¸é°Õ±«£¨¶Ù³§-8201£©
³É·Ö | fam-trastuzumab deruxtecan-nxki | ³¢-×é°±Ëá | ³¢-ÑÎËá×é°±Ëá | ¾ÛɽÀæ´¼õ¥80 | ÕáÌÇ | ×¢ÉäÓÃË® |
º¬Á¿ | 100 mg | 4.45 mg | 20.2 mg | 1.5 mg | 450 mg | 5 mL |
&²Ô²ú²õ±è;°¿±è»å³Ü²¹±ô²¹²µ£¨¸é±ð±ô²¹³Ù±ô¾±³¾²¹²ú£©
³É·Ö | nivolumab | relatlimab | ³¢-×é°±Ëá | ³¢-ÑÎËá×é°±Ëá | Èþ°·ÎåÒÒËá | ÍÂÎÂ80 | ÕáÌÇ |
º¬Á¿£¨Ã¿³¾³¢£© | 12 mg | 4 mg | 1.1 mg | 2.7 mg | 0.008 mg | 0.5 mg | 85.6 mg |
±õ³¾Âá³Ü»å´Ç(°Õ°ù±ð³¾±ð±ô¾±³¾³Ü³¾²¹²ú£¬ÁªºÏ»å³Ü°ù±¹²¹±ô³Ü³¾²¹²ú)
³É·Ö | tremelimumab-actl | ÒÀµØËá¶þÄÆ | ³¢-×é°±Ëá | ³¢-ÑÎËá×é°±Ëá | ÍÂÎÂ80 | º£ÔåÌÇ |
º¬Á¿£¨Ã¿³¾³¢£© | 20 mg | 0.09 mg | 0.68 mg | 3.3 mg | 0.2 mg | 76 mg |